Notice Number: NOT-TR-20-015
Key Dates
Release Date: April 2, 2020
PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)".
Issued by
National Center for Advancing Translational Sciences (NCATS)
Purpose
The purpose of this Notice is to inform applicants that the National Center for Advancing Translational Sciences (NCATS) will participate, effective immediately, in PA-18-935 "Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)".
The following changes and updates are made to PA-18-935 (shown in italics) to reflect NCATS’ participation in this funding opportunity announcement (FOA).
Part 1. Overview Information
Components of Participating Organizations
National Institute on Aging (NIA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Environmental Health Sciences (NIEHS)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Center for Advancing Translational Sciences (NCATS)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866; 93.855; 93.279; 93.847; 93.242, 93.113, 93.272, 93.286, 93.350
All other aspects of this FOA remain the same.
Inquiries
Please direct all inquiries to:
For any scientific or research-related questions on this urgent competitive revisions notice please contact the Program Officer listed on the NoA of the most recent parent award
and Human Services (HHS)
